Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Link opens in a new tab
Search content at Icahn School of Medicine at Mount Sinai
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Relapse, rebound, and psoriasis adverse events: An advisory group report
Wayne Carey
, Scott Glazer
, Alice B. Gottlieb
,
Mark Lebwohl
, Craig Leonardi
, Alan Menter
, Kim Papp
, Amy Chen Rundle
, Darryl Toth
Icahn School of Medicine at Mount Sinai
Waldman Department of Dermatology
Research output
:
Contribution to journal
›
Article
›
peer-review
136
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Relapse, rebound, and psoriasis adverse events: An advisory group report'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Adverse Events
100%
Psoriasis
100%
Advisory Group
100%
Efalizumab
100%
Group Reports
100%
Clinical Trials
40%
National Psoriasis Foundation
40%
Monoclonal Antibody
20%
Chronic Disease
20%
Recombinant
20%
Disease Relapse
20%
Humanized
20%
Clinical Trial Data
20%
Immunoglobulin G
20%
Endocrine Factors
20%
Standardized Definitions
20%
Psychological Stress
20%
Skin Injury
20%
Hypocalcemia
20%
Disease Worsening
20%
Medicine and Dentistry
Adverse Event
100%
Psoriasis
100%
Rebound
100%
Efalizumab
71%
Clinical Trial
42%
Diseases
28%
Monoclonal Antibody
14%
Infection
14%
Chronic Disease
14%
Immunoglobulin G
14%
Mental Stress
14%
Skin Injury
14%
Hypocalcaemia
14%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
100%
Psoriasis
100%
Efalizumab
71%
Clinical Trial
42%
Diseases
28%
Monoclonal Antibody
14%
Infection
14%
Chronic Disease
14%
Immunoglobulin G
14%
Hypocalcaemia
14%
Skin Injury
14%